Aspiration Versus Stent Retriever Thrombectomy for Distal, Medium Vessel Occlusion Stroke in the Posterior Circulation: A Subanalysis of the TOPMOST Study.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
08 2022
Historique:
pubmed: 22 4 2022
medline: 28 7 2022
entrez: 21 4 2022
Statut: ppublish

Résumé

The optimal endovascular strategy for reperfusing distal medium-vessel occlusions (DMVO) remains unknown. This study evaluates angiographic and clinical outcomes of thrombectomy strategies in DMVO stroke of the posterior circulation. TOPMOST (Treatment for Primary Medium Vessel Occlusion Stroke) is an international, retrospective, multicenter, observational registry of patients treated for DMVO between January 2014 and June 2020. This study analyzed endovascularly treated isolated primary DMVO of the posterior cerebral artery in the P2 and P3 segment. Technical feasibility was evaluated with the first-pass effect defined as a modified Thrombolysis in Cerebral Infarction Scale score of 3. Rates of early neurological improvement and functional modified Rankin Scale scores at 90 days were compared. Safety was assessed by the occurrence of symptomatic intracranial hemorrhage and intervention-related serious adverse events. A total of 141 patients met the inclusion criteria and were treated endovascularly for primary isolated DMVO in the P2 (84.4%, 119) or P3 segment (15.6%, 22) of the posterior cerebral artery. The median age was 75 (IQR, 62-81), and 45.4% (64) were female. The initial reperfusion strategy was aspiration only in 29% (41) and stent retriever in 71% (100), both achieving similar first-pass effect rates of 53.7% (22) and 44% (44; Both first-pass aspiration and stent retriever thrombectomy for primary isolated posterior circulation DMVO seem to be safe and technically feasible leading to similar favorable rates of angiographic and clinical outcome.

Sections du résumé

BACKGROUND
The optimal endovascular strategy for reperfusing distal medium-vessel occlusions (DMVO) remains unknown. This study evaluates angiographic and clinical outcomes of thrombectomy strategies in DMVO stroke of the posterior circulation.
METHODS
TOPMOST (Treatment for Primary Medium Vessel Occlusion Stroke) is an international, retrospective, multicenter, observational registry of patients treated for DMVO between January 2014 and June 2020. This study analyzed endovascularly treated isolated primary DMVO of the posterior cerebral artery in the P2 and P3 segment. Technical feasibility was evaluated with the first-pass effect defined as a modified Thrombolysis in Cerebral Infarction Scale score of 3. Rates of early neurological improvement and functional modified Rankin Scale scores at 90 days were compared. Safety was assessed by the occurrence of symptomatic intracranial hemorrhage and intervention-related serious adverse events.
RESULTS
A total of 141 patients met the inclusion criteria and were treated endovascularly for primary isolated DMVO in the P2 (84.4%, 119) or P3 segment (15.6%, 22) of the posterior cerebral artery. The median age was 75 (IQR, 62-81), and 45.4% (64) were female. The initial reperfusion strategy was aspiration only in 29% (41) and stent retriever in 71% (100), both achieving similar first-pass effect rates of 53.7% (22) and 44% (44;
CONCLUSIONS
Both first-pass aspiration and stent retriever thrombectomy for primary isolated posterior circulation DMVO seem to be safe and technically feasible leading to similar favorable rates of angiographic and clinical outcome.

Identifiants

pubmed: 35443785
doi: 10.1161/STROKEAHA.121.037792
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2449-2457

Auteurs

Lukas Meyer (L)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Germany (L.M., P.S., G.B., P.S., J.F., U.H.).

Paul Stracke (P)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Germany (L.M., P.S., G.B., P.S., J.F., U.H.).
Department of Interventional Neuroradiology, University Hospital Muenster, Germany (P.S.).
Department of Diagnostic and Interventional Neuroradiology, University Hospital Basel, Switzerland (P.S., M.P.).

Marta Wallocha (M)

Department of Endovascular Therapy, Alfried-Krupp Hospital Essen, Germany (M.W., R.C.).

Gabriel Broocks (G)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Germany (L.M., P.S., G.B., P.S., J.F., U.H.).

Peter Sporns (P)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Germany (L.M., P.S., G.B., P.S., J.F., U.H.).

Eike I Piechowiak (EI)

Institute of Diagnostic and Interventional Neuroradiology (E.I.P., J.K.), Inselspital, Bern University Hospital, University of Bern, Switzerland.

Johannes Kaesmacher (J)

Institute of Diagnostic and Interventional Neuroradiology (E.I.P., J.K.), Inselspital, Bern University Hospital, University of Bern, Switzerland.
Institute of Diagnostic, Interventional and Pediatric Radiology (J.K.), Inselspital, Bern University Hospital, University of Bern, Switzerland.

Christian Maegerlein (C)

Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, School of Medicine, Technical University Munich, Munich, Germany (C.M., M.R.H.P.).

Moritz Roman Hernandez Petzsche (MR)

Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, School of Medicine, Technical University Munich, Munich, Germany (C.M., M.R.H.P.).

Franziska Dorn (F)

Institute of Neuroradiology, University Hospitals, LMU Munich, Germany (F.D., H.Z.).

Hanna Zimmermann (H)

Institute of Neuroradiology, University Hospitals, LMU Munich, Germany (F.D., H.Z.).

Weis Naziri (W)

Department of Neuroradiology, Westpfalz-Klinikum, Kaiserslautern, Germany (W.N.).
Department of Neuroradiology, University Hospital Luebeck, Germany (W.N.).

Nuran Abdullayev (N)

Department of Neuroradiology, University of Cologne, Germany (N.A., C.K.).

Christoph Kabbasch (C)

Department of Neuroradiology, University of Cologne, Germany (N.A., C.K.).

Daniel Behme (D)

Institute for Diagnostic and Interventional Neuroradiology, University Hospital Goettingen, Germany (D.B., A.J.).

Ala Jamous (A)

Institute for Diagnostic and Interventional Neuroradiology, University Hospital Goettingen, Germany (D.B., A.J.).

Volker Maus (V)

Department of Diagnostic and Interventional Neuroradiology and Nuclear Medicine, Universitätsklinikum Knappschaftskrankenhaus Bochum, Universitätsklinik der Ruhr-Universität Bochum, Germany (V.M., S.F.).

Sebastian Fischer (S)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Germany (L.M., P.S., G.B., P.S., J.F., U.H.).
Department of Diagnostic and Interventional Neuroradiology and Nuclear Medicine, Universitätsklinikum Knappschaftskrankenhaus Bochum, Universitätsklinik der Ruhr-Universität Bochum, Germany (V.M., S.F.).

Markus Möhlenbruch (M)

Department of Neuroradiology, Heidelberg University Hospital, Germany (M.M., C.S.W.).

Charlotte S Weyland (CS)

Department of Neuroradiology, Heidelberg University Hospital, Germany (M.M., C.S.W.).

Sönke Langner (S)

Institute for Diagnostic and Interventional Radiology, Pediatric and Neuroradiology, University Hospital Rostock, Germany (S.L.).

Dan Meila (D)

Department of Interventional Neuroradiology, Johanna-Étienne-Hospital, Neuss, Germany (D.M.).

Milena Miszczuk (M)

Institute of Neuroradiology, Charité Universitätsmedizin Berlin, Germany (M.M., E.S.).

Eberhard Siebert (E)

Institute of Neuroradiology, Charité Universitätsmedizin Berlin, Germany (M.M., E.S.).

Stephan Lowens (S)

Department of Radiology (S.L.), Klinikum Osnabrück, Germany.

Lars Udo Krause (LU)

Department of Neurology (L.U.K.), Klinikum Osnabrück, Germany.

Leonard Yeo (L)

Division of Neurology, Department of Medicine (L.Y., B.T.), National University Health System, Singapore.
Yong Loo Lin School of Medicine, National University of Singapore (L.Y., B.T., A.G.).

Benjamin Tan (B)

Division of Neurology, Department of Medicine (L.Y., B.T.), National University Health System, Singapore.
Yong Loo Lin School of Medicine, National University of Singapore (L.Y., B.T., A.G.).

Anil Gopinathan (A)

Department of Diagnostic imaging (A.G.), National University Health System, Singapore.
Yong Loo Lin School of Medicine, National University of Singapore (L.Y., B.T., A.G.).

Benjamin Gory (B)

Université de Lorraine, CHRU-Nancy, Department of Diagnostic and Therapeutic Neuroradiology, France (B.G.).
Université de Lorraine, IADI, INSERM U1254, F-54000 Nancy, France (B.G.).

Jorge Galván-Fernández (J)

Department of Interventional Neuroradiology, Hospital Clínico Universitario de Valladolid, Spain (J.G.-F., M.S., M.M.-G.).

Miguel Schüller (M)

Department of Interventional Neuroradiology, Hospital Clínico Universitario de Valladolid, Spain (J.G.-F., M.S., M.M.-G.).

Pedro Navia (P)

Department of Neuroradiology, Hospital Universitario La Paz, Madrid, Spain (P.N.).

Eytan Raz (E)

Department of Radiology, New York Langone Medical Center (E.R., M.S.).

Maksim Shapiro (M)

Department of Radiology, New York Langone Medical Center (E.R., M.S.).

Fabian Arnberg (F)

Department of Neuroradiology, Karolinska University Hospital and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden (F.A., T.A.).

Kamil Zeleňák (K)

Department of Radiology, Comenius University's Jessenius Faculty of Medicine and University Hospital, Martin, Slovakia (K.Z.).

Mario Martínez-Galdámez (M)

Department of Interventional Neuroradiology, Hospital Clínico Universitario de Valladolid, Spain (J.G.-F., M.S., M.M.-G.).

Andreas Kastrup (A)

Department of Neurology, Hospital Bremen-Mitte, Germany (A.K.).

Panagiotis Papanagiotou (P)

Department of Diagnostic and Interventional Neuroradiology, Hospital Bremen-Mitte, Germany (P.P.).
Department of Radiology, Areteion University Hospital, National and Kapodistrian University of Athens, Greece (P.P.).

André Kemmling (A)

Department of Neuroradiology, University Hospital Marburg, Germany (A.K.).

Marios Psychogios (M)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Basel, Switzerland (P.S., M.P.).

Tommy Andersson (T)

Department of Neuroradiology, Karolinska University Hospital and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden (F.A., T.A.).
Department of Medical Imaging, AZ Groeninge, Kortrijk, Belgium (T.A.).

Rene Chapot (R)

Department of Endovascular Therapy, Alfried-Krupp Hospital Essen, Germany (M.W., R.C.).

Jens Fiehler (J)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Germany (L.M., P.S., G.B., P.S., J.F., U.H.).

Uta Hanning (U)

Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Germany (L.M., P.S., G.B., P.S., J.F., U.H.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH